Activation of γ-globin expression by LncRNA-mediated ERF promoter hypermethylation in β-thalassemia

Clin Epigenetics. 2024 Jan 13;16(1):12. doi: 10.1186/s13148-023-01614-6.

Abstract

The mechanism that drives the switch from fetal to adult hemoglobin (Hb) provides a therapeutic target for β-thalassemia. We have previously identified that hypermethylation of transcription factor ERF promoter reactivated γ-globin expression. To uncover the mechanism underlying the hypermethylation of ERF promoter, we performed RNA sequencing in β00-thalassemia patients and identified an upregulated long noncoding RNA (RP11-196G18.23) associated with HbF production. RP11-196G18.23 bound to the ERF promoter and recruited DNA methyltransferase 3A to promote DNA hypermethylation-mediated ERF downregulation, thereby ameliorating ERF-induced γ-globin inactivation. The identification of RP11-196G18.23 provides an epigenetic mechanism for the reactivation of fetal γ-globin expression for β-hemoglobinopathies.

Keywords: ERF promoter hypermethylation; Fetal hemoglobin; RP11-196G18.23; β-Thalassemia; γ-Globin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • DNA Methylation
  • Fetal Hemoglobin / genetics
  • Humans
  • RNA, Long Noncoding* / genetics
  • RNA, Long Noncoding* / metabolism
  • Repressor Proteins / genetics
  • beta-Thalassemia* / genetics
  • beta-Thalassemia* / therapy
  • gamma-Globins / genetics
  • gamma-Globins / metabolism

Substances

  • gamma-Globins
  • RNA, Long Noncoding
  • Fetal Hemoglobin
  • ERF protein, human
  • Repressor Proteins